×
Oncology Institute EBIT 2020-2025 | TOI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Oncology Institute ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Oncology Institute EBIT 2020-2025 | TOI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Oncology Institute ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$146.6B
CVS Health (CVS)
$81.9B
Elevance Health (ELV)
$77B
Cencora (COR)
$57.2B
DiDi Global (DIDIY)
$24.2B
Natera (NTRA)
$21.9B
Labcorp Holdings (LH)
$20.9B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$13.7B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.8B
ICON (ICLR)
$12.2B
Revvity (RVTY)
$12B
Viatris (VTRS)
$10.7B
Medpace Holdings (MEDP)
$9.3B
Avantor (AVTR)
$9.3B
Sonic Healthcare (SKHHY)
$8.6B
HealthEquity (HQY)
$8.2B
Charles River Laboratories (CRL)
$7.8B
Caris Life Sciences,�Inc (CAI)
$6.7B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.3B
Surgery Partners (SGRY)
$2.8B
Alignment Healthcare (ALHC)
$2.6B
Organon (OGN)
$2.6B
Concentras Parent (CON)
$2.6B
GeneDx Holdings (WGS)
$2.4B
Ardent Health (ARDT)
$2B